Drug Trial Radar · NCT03920072
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH
Last checked: Nov 20, 2026Latest source record: May 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Mar 7, 2019
Primary completion
Apr 7, 2022
Study completion Apr 7, 2022
Sponsor
- Lead sponsor
- Kyowa Kirin Pharmaceutical Development LtdIndustry
- Sponsor type
- Industry
- First posted
- Apr 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is phase 3b open-label, international, multicenter study to continue to monitor the long-term safety and efficacy of burosumab in adult patients with XLH that participated in previous clinical trials with burosumab (UX023-CL303 / UX023-CL304).
Conditions
- X-linked Hypophosphatemia
Interventions
BurosumabDrug
Burosumab is a sterile, clear, colourless and preservative free solution supplied in single-use 5ml vials containing 1mL of burosumab at a concentration of 30mg/mL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects achieving mean serum phosphorus levels above the LLN (2.5mg/dL[0.81mmol/L]), as averaged across dose cycles between baseline and their last administered dose.Time frame: Serum phosphorous levels will be monitored from Screening and every 12 weeks until the end of the study, at approximately 144 weeks.
Locations
10 sites in 4 countries. Site status is shown where the registry gives one.
CHU de Bicetre
Le Kremlin-Bicêtre, France
Hopital Lariboisiere
Paris, France
Hopital Cochin
Paris, France
St. Vincent's University Hospital
Dublin, Ireland
Azienda ospedaliera universitaria Careggi
Florence, Italy
Western General Hospital
Edinburgh, United Kingdom
National Hospital for Neurology and Neurosurgery-University College London Hospitals NHS Foundation Trust
London, United Kingdom
Nuffield Orthopaedic Centre - Oxford University Hospitals Nhs Trust
Oxford, United Kingdom
Northen General Hospital
Sheffield, United Kingdom
Royal National Orthopaedic Hospital NHS Trust
Stanmore, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.